Quick Answer
Arteris, Inc. reported Cash and Equivalents of $33.90 million for fiscal year 2025.
Arteris, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $33.90M | +147.7% |
| 2024 | $13.68M | -0.1% |
| 2023 | $13.70M | -63.4% |
| 2022 | $37.42M | -56.4% |
| 2021 | $85.83M | +630.8% |
| 2020 | $11.74M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $17.42M | -2.3% | +8.2% |
| June 30, 2025 | $16.10M | -27.2% | -1.7% |
| March 31, 2025 | $16.37M | -37.3% | +19.6% |
| December 31, 2024 | $13.68M | -0.1% | -23.2% |
| September 30, 2024 | $17.83M | -4.3% | -19.4% |
| June 30, 2024 | $22.13M | -16.0% | -15.3% |
| March 31, 2024 | $26.12M | -8.4% | +90.7% |
| December 31, 2023 | $13.70M | -63.4% | -26.5% |
- Arteris, Inc. showed an increase of +147.7% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2020–2025 period, Arteris, Inc.’s cash and equivalents has grown by 188.7% (from $11.74 million to $33.90 million).
- The most recent figure is from Arteris, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: